QUOTED. 22 December. Jeff Hawkins.
The pandemic has ushered in a new era in point-of-care testing in which technologies are increasingly becoming more accessible, more affordable and more convenient, according to a panel discussion at the recent virtual AACC 2020 conference. See what panelist Jeff Hawkins, CEO of Truvian Sciences, said about it here.
“There is something really interesting not just from a clinical outcomes perspective, but also from a health economics perspective and consumer preferences that are going to start making the landscape be very different for point-of-care companies as we introduce [tests] to the market.” – Jeff Hawkins, CEO, Truvian Sciences
- Find out more: AACC 2020: COVID-19 Paved Way For ‘Retailization,’ Innovation In Point-Of-Care Testing, Now What?
Click here for a free trial of Medtech Insight